rs587777324
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP2PP5
The NM_001069.3(TUBB2A):c.743C>T(p.Ala248Val) variant causes a missense change involving the alteration of a conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001069.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 400AN: 111804Hom.: 0 Cov.: 16 FAILED QC
GnomAD3 exomes AF: 0.0000337 AC: 8AN: 237044Hom.: 0 AF XY: 0.0000308 AC XY: 4AN XY: 129760
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000103 AC: 15AN: 1457164Hom.: 0 Cov.: 30 AF XY: 0.00000690 AC XY: 5AN XY: 724782
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00360 AC: 403AN: 111864Hom.: 0 Cov.: 16 AF XY: 0.00361 AC XY: 191AN XY: 52854
ClinVar
Submissions by phenotype
Complex cortical dysplasia with other brain malformations 5 Pathogenic:7Uncertain:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
- -
- -
- -
- -
- -
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0104 - Dominant negative is a likely mechanism of disease in this gene and is associated with cortical dysplasia, complex, with other brain malformations 5, (MIM#615763). Functional studies have shown missense variants to cause weakened incorporation into cytoskeleton, and potentially impaired heterodimer formation indicating loss of function. However, the mutational spectrum is more suggestive of a dominant negative mechanism (PMID: 24702957). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from alanine to valine. (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) <0.001 for a dominant condition (400 heterozygotes, 0 homozygotes). However, most of these are likely sequencing artefacts. The remaining were observed in individuals with a neurodevelopmental disorder (PMID: 33547136). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v3) (1 heterozygote, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0603 - Missense variant in a region that is highly intolerant to missense variation (high constraint region in DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported once each as a VUS and likely benign; however, the majority of submissions are pathogenic and likely pathogenic (ClinVar). It has also been observed multiple times as de novo in individuals with simplified gyral patterning and infantile-onset epilepsy (PMID: 24702957, PMID: 32203252). (SP) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed, by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
not provided Pathogenic:3
Published functional studies demonstrate that this variant has a reduced rate of heterodimer incorporation into the in vitro cytoskeleton network in comparison with wild type-expressing cells (Cushion et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 26934450, 24702957, 27770045, 32203252, 32571897) -
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 248 of the TUBB2A protein (p.Ala248Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with TUBB2A-related conditions (PMID: 24702957, 27770045, 32203252, 32571897; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 127101). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TUBB2A protein function. Experimental studies have shown that this missense change affects TUBB2A function (PMID: 24702957, 29547997). For these reasons, this variant has been classified as Pathogenic. -
- -
Inborn genetic diseases Uncertain:1
The c.743C>T (p.A248V) alteration is located in exon 4 (coding exon 4) of the TUBB2A gene. This alteration results from a C to T substitution at nucleotide position 743, causing the alanine (A) at amino acid position 248 to be replaced by a valine (V). Based on data from the Genome Aggregation Database (gnomAD) database, the TUBB2A c.743C>T alteration was observed in 0.03% (87/252926) of total alleles studied, with a frequency of 0.37% (68/18432) in the African subpopulation; however, this data may be an unreliable mismapping artefact (Ragoussis, 2021). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not specified Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at